Vemurafenib for BRAF V600 mutated advanced melanoma: Results of treatment beyond progression

  • A. Scholtens
  • , M. H. Geukes Foppen
  • , C. U. Blank
  • , J. V. Van Thienen
  • , H. Van Tinteren
  • , J. B. Haanen

Research output: Contribution to journalArticlepeer-review

32 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Vemurafenib for BRAF V600 mutated advanced melanoma: Results of treatment beyond progression'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science